Huvist is a biotechnology and pharmaceutical startup, founded in 2014, that focuses on developing an array of advanced, high-quality prescription drugs and innovative health products. With the slogan, "Crafting the future of pharmaceuticals," the company aims to revolutionize the pharmaceutical industry. Huvist's expertise lies in the development and manufacturing of various pharmaceutical products, including prescription drugs, tablets, capsules, masks, and more. In terms of funding, the company received a Venture Round investment on 01 January 2018, with TS Investment as the sole investor. This investment signifies the confidence that TS Investment has in Huvist's potential to make significant strides in the pharmaceutical and biotechnology sectors. Overall, Huvist presents an intriguing opportunity for venture capitalists looking to invest in the future of pharmaceuticals and innovative health solutions.
No recent news or press coverage available for Huvist.